Neptune Wellness Solutions Inc (NASDAQ:NEPT) (TSE:NTB) has been given a consensus broker rating score of 1.50 (Buy) from the two analysts that cover the stock, Zacks Investment Research reports. One investment analyst has rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. Neptune Wellness Solutions’ rating score has declined by 50% in the last three months as a result of various analysts’ ratings changes.
Analysts have set a 1-year consensus price objective of $5.66 for the company and are predicting that the company will post ($0.02) earnings per share for the current quarter, according to Zacks. Zacks has also assigned Neptune Wellness Solutions an industry rank of 93 out of 255 based on the ratings given to its competitors.
A number of research analysts have weighed in on the company. BidaskClub lowered Neptune Wellness Solutions from a “hold” rating to a “sell” rating in a report on Saturday, February 9th. Zacks Investment Research upgraded Neptune Wellness Solutions from a “hold” rating to a “buy” rating and set a $3.75 price target on the stock in a report on Wednesday, March 13th. GMP Securities started coverage on Neptune Wellness Solutions in a report on Tuesday, April 9th. They set a “buy” rating on the stock. Finally, Echelon Wealth Partners reiterated a “buy” rating on shares of Neptune Wellness Solutions in a report on Wednesday, January 9th.
Hedge funds and other institutional investors have recently bought and sold shares of the company. Parallel Advisors LLC raised its holdings in shares of Neptune Wellness Solutions by 25.0% during the 4th quarter. Parallel Advisors LLC now owns 20,000 shares of the biotechnology company’s stock worth $50,000 after acquiring an additional 4,000 shares during the period. Fisher Asset Management LLC purchased a new position in shares of Neptune Wellness Solutions during the 4th quarter worth $51,000. Wells Fargo & Company MN raised its holdings in shares of Neptune Wellness Solutions by 236,363.6% during the 3rd quarter. Wells Fargo & Company MN now owns 26,011 shares of the biotechnology company’s stock worth $101,000 after acquiring an additional 26,000 shares during the period. Renaissance Technologies LLC raised its holdings in shares of Neptune Wellness Solutions by 696.0% during the 3rd quarter. Renaissance Technologies LLC now owns 93,654 shares of the biotechnology company’s stock worth $363,000 after acquiring an additional 81,889 shares during the period. Finally, Two Sigma Advisers LP purchased a new position in shares of Neptune Wellness Solutions during the 4th quarter worth $367,000. Institutional investors and hedge funds own 14.67% of the company’s stock.
Shares of NEPT stock opened at $3.56 on Thursday. The firm has a market capitalization of $279.88 million, a price-to-earnings ratio of 20.94 and a beta of 1.84. Neptune Wellness Solutions has a fifty-two week low of $2.31 and a fifty-two week high of $5.14.
Neptune Wellness Solutions (NASDAQ:NEPT) (TSE:NTB) last announced its quarterly earnings data on Wednesday, February 13th. The biotechnology company reported ($0.04) earnings per share for the quarter. The firm had revenue of $4.95 million during the quarter. Neptune Wellness Solutions had a negative net margin of 60.48% and a negative return on equity of 18.85%. As a group, equities research analysts forecast that Neptune Wellness Solutions will post -0.06 earnings per share for the current fiscal year.
About Neptune Wellness Solutions
Neptune Wellness Solutions Inc, a health and wellness products company, engages in the extraction, purification, and formulation of value-added differentiated science based products. It develops turnkey nutrition product solutions in various delivery forms. The company offers specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils.
Featured Article: The basics of gap trading strategies
Get a free copy of the Zacks research report on Neptune Wellness Solutions (NEPT)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Neptune Wellness Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Wellness Solutions and related companies with MarketBeat.com's FREE daily email newsletter.